Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Other Non Operating Income (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Other Non Operating Income for 6 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 543.0% to -$4.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.3 million, a 66.83% increase, with the full-year FY2025 number at -$4.3 million, up 66.83% from a year prior.
  • Other Non Operating Income was -$4.6 million for Q4 2025 at GeneDx Holdings, down from -$174000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $5.6 million in Q1 2021 to a low of -$13.5 million in Q2 2024.
  • A 5-year average of -$585611.1 and a median of $19500.0 in 2022 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: crashed 56800.0% in 2023, then soared 464.86% in 2025.
  • GeneDx Holdings' Other Non Operating Income stood at $50000.0 in 2021, then crashed by 102.0% to -$1000.0 in 2022, then tumbled by 4800.0% to -$49000.0 in 2023, then crashed by 1357.14% to -$714000.0 in 2024, then tumbled by 543.0% to -$4.6 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Other Non Operating Income are -$4.6 million (Q4 2025), -$174000.0 (Q3 2025), and $239000.0 (Q2 2025).